Balancing access to appropriate treatment for patients with chronic and end-of-life pain

Washington, DC - The opioid epidemic continues to take an emotional, physical and financial toll on Americans. The U.S. Food and Drug Administration is committed to taking every possible step to address the many facets of this complex public health crisis.

Expanded Access to Prevention Programs and Acknowledging Increased Risk of Depression Among People with Diabetes Can Reduce Complications and Prevalence

Orlando, Florida - Diabetes is a unique and complex disease affecting more than 30 million Americans, and the individual living with diabetes is solely responsible for daily diabetes management. The added stress of this responsibility significantly increases their risk for depression and anxiety.

FDA approves automated insulin delivery and monitoring system for use in younger pediatric patients

Washington, DC - The U.S. Food and Drug Administration Thursday expanded the approval of the MiniMed 670G hybrid closed looped system, a diabetes management device that is intended to automatically monitor glucose (sugar) and provide appropriate basal insulin doses with little or no input from the user, to include individuals aged 7 to 13 with type 1 diabetes. The FDA originally approved this device in September 2017 for use in patients 14 years of age and older with type 1 diabetes.

New hypertension center certification aims to improve the outcomes of patients with complex or difficult-to-treat hypertension

Dallas, Texas - Physician practices now have access to new resources to improve their standard of quality care for hypertension treatment based on the latest science. A new certification offered by the American Heart Association, the world’s leading voluntary health organization devoted to fighting cardiovascular disease, aims to improve the outcomes of patients with complex or difficult-to-treat hypertension while partnering with medical practices and implementing evidence-based hypertension treatment guidelines.

Tobacco aside, e-cigarette flavorings may harm blood vessels

Dallas, Texas - Flavor additives used in electronic cigarettes and related tobacco products could impair blood vessel function and may be an early indicator of heart damage, according to new laboratory research in Arteriosclerosis, Thrombosis and Vascular Biology, an American Heart Association journal.